Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.
BACKGROUND: Radiofrequency ablation (RFA), combined with endoscopic resection, can be used as a primary treatment for low grade dysplasia, high grade dysplasia, and early esophageal adenocarcinoma (EAC) in Barrett's esophagus (BE). The aim of the Belgian RFA registry is to capture the real-life outcome of endoscopic therapy for BE with RFA and to assess efficacy and safety outside study protocols, in the absence of reimbursement. PATIENTS AND METHODS: Between February 2008 and January 2017, data from 7 different expert centers were prospectively collected in the registry. Efficacy outcomes inc... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Verlag/Hrsg.: |
Georg Thieme Verlag
|
Schlagwörter: | Adenocarcinoma / Barrett Esophagus / Belgium / Catheter Ablation / Esophageal Neoplasms / Esophagoscopy / Female / Humans / Male / Middle Aged / Neoplasm Recurrence / Local / Precancerous Conditions / Registries / Treatment Outcome |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28944364 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/237274 |